Bottom line
What is DOXBX's expense ratio?
DOXBX's expense ratio is 0.42%, or about $42 a year on every $10,000 invested. That is cheaper than 92% of allocation / balanced funds we track (median 0.91%). It has no front-end sales load.
Updated Apr 22, 2026
DOXBX fee table
| Net expense ratio | 0.42% |
|---|---|
| Gross expense ratio | 0.48% |
| Management fee | 0.45% |
| 12b-1 (distribution) fee | 0% |
| Other expenses | 0.02% |
| Acquired fund fees | 0.01% |
| Fee waiver / reimbursement | -0.06% |
| Max front-end sales load | 0% |
| Max deferred sales charge | 0% |
| Redemption fee | 0% |
Source: Fund prospectus fee table, filed Apr 22, 2026
What DOXBX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| DOXBX | $43 | $137 | $252 | $587 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 0.42% expense ratio costs roughly $24,500 in lost growth, versus about $50,800 for the median allocation / balanced fund (0.91%).